Cite
HARVARD Citation
Huang, Q. et al. (2021). All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet. 8 (10), pp. e688-e699. [Online].